RISSCI-1 Blood Cholesterol Response Study (RISSCI-1)
Reading Imperial Surrey Saturated Fat Cholesterol Intervention (RISSCI) Study. RISSCI-1 Blood Cholesterol Response Study
Sponsor: Imperial College London
Listed as NCT03270527, this NA trial focuses on Healthy and Lipid Metabolism and remains completed. Sponsored by Imperial College London, it has been updated 9 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Nov 2021 — Jul 2024 [monthly]
Completed NA
Status: Unknown Status → Completed
-
Oct 2021 — Nov 2021 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jan 2021 — Oct 2021 [monthly]
Recruiting NA
▶ Show 4 earlier versions
-
Jun 2019 — Jan 2021 [monthly]
Recruiting NA
-
Jun 2018 — Jun 2019 [monthly]
Recruiting NA
-
Nov 2017 — Jun 2018 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Oct 2017 — Nov 2017 [monthly]
Not Yet Recruiting NA
First recorded
Sep 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Imperial College London
- University of Reading
- University of Surrey
For direct contact, visit the study record on ClinicalTrials.gov .